GeneDx Holdings Corp. Other Income and Expense
GeneDx Holdings Corp. (WGS) reported Other Income and Expense of -$803.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-03
- GeneDx Holdings Corp. nonoperating income (expense) for the quarter ending 2026-06-30 was -$803.00K, a 150.09% decline year-over-year.
- GeneDx Holdings Corp. nonoperating income (expense) for the quarter ending 2026-03-31 was -$4.95M.
- GeneDx Holdings Corp. nonoperating income (expense) for the quarter ending 2025-12-31 was -$4.00M.
- GeneDx Holdings Corp. nonoperating income (expense) for the quarter ending 2025-09-30 was -$4.14M.
- GeneDx Holdings Corp. nonoperating income (expense) for fiscal 2025 was -$8.06M.
- GeneDx Holdings Corp. nonoperating income (expense) for fiscal 2024 was -$29.42M, a 853.68% decline from fiscal 2023.
- GeneDx Holdings Corp. nonoperating income (expense) for fiscal 2023 was $3.90M, a 94.39% decline from fiscal 2022.
- GeneDx Holdings Corp. nonoperating income (expense) for fiscal 2022 was $69.62M, a 65.32% decline from fiscal 2021.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$803.00K 10-Q · filed 2026-08-03 | -$5.75M 10-Q · filed 2026-08-03 | -$9.75M derived: sum of 3 quarters · filed 2026-08-03 | -$13.88M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$4.95M 10-Q · filed 2026-05-04 | -$8.94M derived: sum of 2 quarters · filed 2026-05-04 | -$13.08M derived: sum of 3 quarters · filed 2026-05-04 | -$11.48M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$8.13M derived: sum of 2 quarters · filed 2026-02-23 | -$6.53M derived: sum of 3 quarters · filed 2026-08-03 | -$8.06M 10-K · filed 2026-02-23 |
| 2025-09-30 | -$4.14M 10-Q · filed 2025-10-28 | -$2.53M derived: sum of 2 quarters · filed 2026-08-03 | -$4.07M 10-Q · filed 2025-10-28 | -$7.46M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $1.60M 10-Q · filed 2026-08-03 | $72.00K 10-Q · filed 2026-08-03 | -$3.32M derived: sum of 3 quarters · filed 2026-08-03 | -$3.90M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$1.53M 10-Q · filed 2026-05-04 | -$4.92M derived: sum of 2 quarters · filed 2026-05-04 | -$5.50M derived: sum of 3 quarters · filed 2026-05-04 | -$24.29M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$3.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$3.97M derived: sum of 2 quarters · filed 2026-02-23 | -$22.75M derived: sum of 3 quarters · filed 2026-02-23 | -$29.42M 10-K · filed 2026-02-23 |
| 2024-09-30 | -$579.00K 10-Q · filed 2025-10-28 | -$19.36M derived: sum of 2 quarters · filed 2025-10-28 | -$26.02M 10-Q · filed 2025-10-28 | -$26.57M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | -$18.78M 10-Q · filed 2025-07-29 | -$25.45M 10-Q · filed 2025-07-29 | -$25.99M derived: sum of 3 quarters · filed 2026-02-23 | -$25.48M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | -$6.66M 10-Q · filed 2025-04-30 | -$7.20M derived: sum of 2 quarters · filed 2026-02-23 | -$6.69M derived: sum of 3 quarters · filed 2026-02-23 | -$1.99M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | -$541.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | -$32.00K derived: sum of 2 quarters · filed 2026-02-23 | $4.67M derived: sum of 3 quarters · filed 2026-02-23 | $3.90M 10-K · filed 2026-02-23 |
| 2023-09-30 | $509.00K 10-Q · filed 2024-10-29 | $5.22M derived: sum of 2 quarters · filed 2024-10-29 | $4.44M 10-Q · filed 2024-10-29 | $20.66M derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $4.71M 10-Q · filed 2024-07-30 | $3.94M 10-Q · filed 2024-07-30 | $20.15M derived: sum of 3 quarters · filed 2024-07-30 | $33.32M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | -$772.00K 10-Q · filed 2024-04-29 | $15.44M derived: sum of 2 quarters · filed 2024-04-29 | $28.61M derived: sum of 3 quarters · filed 2024-04-29 | $56.44M derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | $16.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $29.38M derived: sum of 2 quarters · filed 2024-02-23 | $57.21M derived: sum of 3 quarters · filed 2024-02-23 | $69.62M 10-K · filed 2024-02-23 |
| 2022-09-30 | $13.17M 10-Q · filed 2023-11-03 | $41.00M derived: sum of 2 quarters · filed 2023-11-03 | $53.41M 10-Q · filed 2023-11-03 | $129.00M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $27.83M 10-Q · filed 2023-08-08 | $40.24M 10-Q · filed 2023-08-08 | $115.83M derived: sum of 3 quarters · filed 2023-08-08 | $236.83M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $12.41M 10-Q · filed 2023-05-09 | $88.00M derived: sum of 2 quarters · filed 2023-05-09 | $209.00M derived: sum of 3 quarters · filed 2023-05-09 | $208.29M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $75.59M 10-K · filed 2022-03-14 | $196.59M derived: sum of 2 quarters · filed 2022-11-14 | $195.88M derived: sum of 3 quarters · filed 2022-11-14 | $200.76M 10-K · filed 2023-03-16 |
| 2021-09-30 | $121.00M 10-Q · filed 2022-11-14 | $120.28M derived: sum of 2 quarters · filed 2022-11-14 | $125.16M 10-Q · filed 2022-11-14 | $124.53M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$713.00K 10-Q · filed 2022-08-15 | $4.17M 10-Q · filed 2022-08-15 | $3.53M derived: sum of 3 quarters · filed 2022-08-15 | $2.93M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $4.88M 10-Q · filed 2022-05-12 | $4.24M derived: sum of 2 quarters · filed 2022-05-12 | $3.64M derived: sum of 3 quarters · filed 2022-05-12 | $5.75M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$638.00K 10-K · filed 2022-03-14 | -$1.24M derived: sum of 2 quarters · filed 2022-03-14 | $872.00K derived: sum of 3 quarters · filed 2022-03-14 | $654.00K 10-K · filed 2023-03-16 |
| 2020-09-30 | -$600.00K 10-K · filed 2022-03-14 | $1.51M derived: sum of 2 quarters · filed 2022-03-14 | $1.29M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $2.11M 10-K · filed 2022-03-14 | $1.89M derived: sum of 2 quarters · filed 2022-03-14 | ||
| 2020-03-31 | -$218.00K 10-K · filed 2022-03-14 | |||
| 2019-12-31 | $709.00K 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |